The mechanism of neurotoxicity of Clostridium perfringens epsilon toxin to the mouse brain was investigated. Intravenous injection in mice with the toxin caused seizure and excited hippocampal neurons. Microdialysis revealed that epsilon toxin induced excessive glutamate release in the hippocampus. Both the seizure and glutamate release were attenuated by prior injection with riluzole, an inhibitor of presynaptic glutamate release, suggesting that this toxin enhances glutamate efflux, leading to seizure and hippocampal neuronal damage. ß
Introduction
Epsilon toxin is a major virulence determinant of Clostridium perfringens types B and D, which cause fetal enterotoxemia of domestic animals [1] . Neurologic features, such as tremor and opisthotonus, which are characteristically observed during the course of the enterotoxemia [2] , can be induced by epsilon intoxication in experimental models [3, 4] . The toxin accumulates mainly in the brain and a high-a¤nity binding site for epsilon toxin exists in the synaptosomal membrane [5, 6] . Neuronal damage produced in rats by epsilon toxin was recently characterized [4, 7] ; progressive cytoplasmic vacuolation or shrunken hyperchromatic cells with nuclear pyknosis were observed in the brain. Thus, the neurotoxicity of epsilon toxin can be regarded as being responsible for the pathogenesis of the fatal enterotoxemia caused by the organism. Although complex formation of epsilon toxin leading to permeabilization of the cell membrane has been implicated in the cell toxicity of epsilon toxin towards Madin Darby canine kidney cells [8, 9] , the molecular mechanism of epsilon tox-in neurotoxicity is unknown. In the previous paper, we showed that the hippocampal neurons of the rat brain are highly sensitive to epsilon toxin, and suggested that glutamate is involved in the neurotoxicity towards the hippocampus, based on the results from pathological and histochemical analyses [4] . To gain a better understanding of how epsilon toxin elicits neuronal damage, we have characterized its neurotoxicity towards the mouse hippocampus by means of neurophysiological examinations, i.e. measurement of seizure activity, electroencephalographic analysis, and determination of extracellular glutamate levels.
Materials and methods

Animals and toxin administration
Epsilon-prototoxin was puri¢ed from cultures of C. perfringens type B NCIB 10691 [10] . It was activated by tryptic digestion and then diluted with a 1% Bacto peptonesaline solution to avoid overdigestion as described previously [10] . The 50% mouse lethal dose (LD 50 ) of the activated toxin used in this study was approximately 70 ng kg 31 of body weight, similar to that described previously 0378-1097 / 00 / $20.00 ß 2000 Federation of European Microbiological Societies. Published by Elsevier Science B.V. All rights reserved. PII: S 0 3 7 8 -1 0 9 7 ( 0 0 ) 0 0 2 6 2 -7 [10] . Male ddN mice weighing 25^30 g were injected intravenously (i.v.) with 2 or 4 LD 50 of epsilon toxin or vehicle (1% Bacto peptone-saline solution containing trypsin). When riluzole (2-amino-6-tri£uoromethoxy-benzothiazole; Research Biochemicals Inc., Natick, MA, USA), an inhibitor of pre-synaptic glutamate release [11] , was used, it was dissolved in sterile saline solution, and then injected intraperitoneally into mice at a dose of 16 mg kg 31 of body weight 30 min before administration of epsilon toxin. All animal experiments were carried out in accordance with the guidelines described in the Guiding Principles for the Care and Use of Animals approved by the Council of the Physiological Society of Japan.
Measurement of seizure activity and electrocorticogram (ECoG) analysis
Seizure was observed for 2.5 h post-injection (p.i.) and scored according to Racine's classi¢cation [12] : stage 1, mouth and facial movement; 2, plus head nodding; 3, plus forelimb clonus ; 4, plus rearing; and 5, plus bilateral clonic seizure with rearing and falling over. ECoGs were recorded by using electrodes implanted as described in Fig. 2D . Bipolar insulated electrodes were implanted on the dorsal hippocampus under barbiturate anesthesia (30 mg kg 31 of body weight). Unipolar electrodes were also inserted into frontal and occipital lobes. One week after implant surgery, ECoGs were recorded before and after injection of 2 LD 50 of the toxin with a model 2417 polygraph (NEC San-Ei Co., Tokyo, Japan).
Measurement of glutamate levels in the hippocampus
Extracellular glutamate in the mouse hippocampus was measured by a dialysis electrode technique as described elsewhere [13] . Brie£y, a dialysis electrode (Microdialysis Biosensor; Sycopel International Ltd., London, USA) was ¢lled with perfusion solution consisting of 10 mM phosphate-bu¡ered saline (pH 7.4) containing glutamate oxidase (100 U ml 31 ; Yamasa Co. Ltd., Chiba, Japan). The perfusion solution entered the £uid inlet tube at a rate of 0.2 Wl min 31 by means of a perfusion pump (IP-2 ; Bio Research Center Co. Ltd., Nagoya, Japan). Mice were intubated (PE-50 tubing) by tracheotomy under ether anesthesia and placed in a stereotaxic apparatus (Narishige, Tokyo, Japan) under ether anesthesia. They were maintained on a mechanical ventilator (KN-55, Natume Co. Ltd., Tokyo, Japan) as described previously [14] with 1% halothane in 60% N 2 O and 40% O 2 . After surgery, the halothane was discontinued and the mice were immobilized with pancuronium bromide (Sigma, St. Louis, MO, USA) at a dose of 0.5 mg kg 31 (intraperitoneal injection), and supplemental doses were given intermittently as necessary. The dialysis electrode was directed to the CA1 sub¢eld of the dorsal hippocampus (1.9 mm posterior to the bregma, 1.5 mm to the right of the midline, and 1.5 mm depth from the dura [15] ). After stabilization of the electric current, 2 LD 50 or 4 LD 50 of epsilon toxin was injected i.v. from a tail vein and extracellular glutamate levels were measured for 2.5 h p.i. Riluzole was also injected to some mice out of the 4 LD 50 group. The brains of all groups were removed after glutamate measurement under anesthesia with barbiturate (65 mg kg 31 of body weight), sliced, stained with hematoxylin-eosin and then checked for the position of the electrode under a light microscope. Data from areas outside the dorsal hippocampus were excluded from the study.
Statistics
Changes in extracellular glutamate levels, hippocampal blood £ow and seizure activity were statistically analyzed using two-way analysis of variance (ANOVA) followed by Sche¡ë's test, unpaired t-test and Kruskal^Wallis test followed by the Mann^Whitney U-test, respectively. A probability level of 6 0.05 was regarded as statistically signi¢cant.
Results and discussion
Mice injected with 2 LD 50 and 4 LD 50 of the toxin developed seizure within 60 min p.i. (Fig. 1 ). Furthermore, prior injection with riluzole signi¢cantly suppressed the Fig. 1 . Changes in epsilon toxin-induced seizure activity. epsilon toxin was injected i.v. into mice at zero time in the following doses: 2 LD 50 (n = 6) and 4 LD 50 (n = 10). One of the groups injected with 4 LD 50 of the toxin had been intraperitoneally injected with riluzole (16 mg kg 31 of body weight, n = 5) 30 min before administration of the toxin. Data are presented as means þ S.E.M. Symbols : O, group injected with 2 LD 50 of epsilon toxin; a, group injected with 4 LD 50 of the toxin; b, group pre-injected with riluzole and later injected with 4 LD 50 of the toxin; *P 6 0.05 and **P 6 0.01 (versus the group injected with 4 LD 50 of the toxin). seizure induced by epsilon toxin (+riluzole versus 3riluzole at 60, 90 and 150 min, P 6 0.01; +riluzole versus 3riluzole at 120 min, P 6 0.05).
The ECoG of a mouse, which developed stage 5 seizure at 2.5 h p.i., is shown in Fig. 2 as the most prominent ECoG, although the average seizure activity at 2.5 h p.i. in the 2 LD 50 group was stage 3. Multiple spikes were observed in the ECoGs from the hippocampal area at 1.5 h p.i. In contrast, no clear spike was observed in the ECoGs from the other areas. Such a di¡erence in ECoG between the hippocampal and other areas was also observed at 1 h p.i. when seizure was induced (data not shown). At 2.5 h Fig. 2 . ECoG of the mouse injected with epsilon toxin. Five mice were injected i.v. with 2 LD 50 of the toxin and subjected to ECoG analysis. A, B and C are ECoGs recorded 30 min before the toxin injection, 1.5 and 2.5 h p.i., respectively. Note that clear spike waves were observed in the hippocampus area at 1.5 h p.i., while seizure discharge was shown in all the brain areas at 2.5 h p.i. The numbers in D indicate the position of electrodes in the mouse brain: 1 and 2, unipolar electrodes to frontal lobe (1 mm anterior to the bregma, 1.5 mm bilateral of the midline, 1 mm depth from the skull) ; 3 and 4, bipolar electrodes to dorsal hippocampus (1.9 mm posterior to the bregma, 1.5 mm to the left of the midline, 1.5 mm depth from the skull) ; 5, a unipolar electrode to occipital lobe (3.8 mm posterior, 2 mm to the left of the midline, 1 mm depth from the skull). The combinations of 1^3, 1^4, 2^3, 2^4, 3^4 and 3^5 are corresponding to ECoGs from the hippocampal region. p.i., when the mouse developed stage 5 seizure, seizure discharge was shown in all the brain areas tested. The result that epsilon toxin preferentially excited hippocampal neurons supports our previous suggestion that the hippocampal neurons are highly sensitive to epsilon toxin [4] .
Extracellular glutamate levels in the hippocampus determined before and after injection of epsilon toxin are shown in Fig. 3 . They were signi¢cantly elevated by epsilon toxin dose-and time-dependently (main e¡ect of groups F 3Y241 = 137.77, P 6 0.0001 ; main e¡ect of time F 11Y241 = 34.47, P 6 0.0001). There was also signi¢cant group x time interaction (F 33Y241 = 4.91, P = 0.0001), indicating that epsilon toxin clearly induces glutamate release. Extracellular glutamate levels began to increase at 30 min p.i. of the toxin in both 2 LD 50 and 4 LD 50 groups. Injection with 4 LD 50 of epsilon toxin increased the extracellular glutamate levels up to approximately 6-fold more than that with the vehicle alone (P 6 0.0001). Pre-injection of riluzole signi¢cantly suppressed the glutamate levels in the 4 LD 50 group (P 6 0.0001). Pyramidal cells in the mouse hippocampus also shrank and exhibited karyopyknosis by the toxin, as was previously observed for the rat hippocampus [4] . These results suggest that epsilon toxin increases glutamate release from pre-synapse and thereby causes both seizure and hippocampal damage.
Various factors including ischemia easily induce excess release of glutamate, which is toxic to the neurons of the brain, and especially to those of the hippocampus [18, 19] . In the previous paper, we examined the e¡ects of sublethal and lethal doses of epsilon toxin on the cerebral blood £ow (CBF), and showed that the toxin had no signi¢cant e¡ect on CBF in rats [4] . In this study, higher doses (2 and 4 LD 50 ) of the toxin were used to examine early neurophysiological changes in the mouse brain. We therefore determined changes in CBF after injection with 4 LD 50 of the toxin in the same manner as described previously [4] except for the di¡erence of the animals used. There was no signi¢cant di¡erence in CBF during 2.5 h p.i. between the toxin-injected and control groups (data not shown), eliminating the possibility that the excessive glutamate release observed for the toxin-injected groups was due to brain ischemia. Although no appreciable brain edema was observed under the condition used, potential toxicity of epsilon toxin toward the endothelia of brain blood vessels remains to be examined.
The present study focused on the e¡ect of epsilon toxin on the glutamatergic hippocampal neurons. The possibility that other neurotransmitters are also involved in the neurotoxicity of epsilon toxin remains to be examined. Several attempts have been made to develop a recombinant epsilon toxin vaccine to circumvent problems associated with the epsilon-toxoid vaccine [20, 21] . A therapeutic approach to the enterotoxemia caused by C. perfringens may also bene¢t economically important livestock. The ¢nding that riluzole, a recently released drug for the treatment of human amyotrophic lateral sclerosis [22] , attenuates the seizure activity evoked by epsilon intoxication would provide a feasible strategy for developing a pharmacotherapy of enterotoxemic brain injury. Fig. 3 . Changes in extracellular glutamate levels of the mouse hippocampus by epsilon intoxication and an e¡ect of pre-injection with riluzole on glutamate e¥ux. epsilon toxin or vehicle was injected i.v. into mice at zero time. A single injection was given to four groups with vehicle (n = 5), 2 LD 50 (n = 7), 4 LD 50 (n = 10), 4 LD 50 with pre-injection of riluzole (n = 7) of epsilon toxin. Riluzole (16 mg kg 31 of body weight) had been injected intraperitoneally 30 min before administration of the toxin. Data are presented as means þ S.E.M. Symbols : E, control (vehicle alone); O, group injected with 2 LD 50 of epsilon toxin; a, group injected with 4 LD 50 of the toxin; b, group pre-injected with riluzole and later injected with 4 LD 50 of the toxin.
